Anti-Obesity Medication, also known as weight loss drugs, are medications that are prescribed to help individuals lose weight. These drugs work by decreasing appetite, increasing feelings of fullness, or blocking the absorption of fat in the body. Some commonly prescribed anti-obesity medications include Orlistat, Phentermine, and Liraglutide. It’s important to note that these medications should be used in conjunction with a healthy diet and exercise program, and should only be taken under the supervision of a healthcare provider.
Weight Loss Drugs
Weight loss drugs, also known as anti-obesity medication, are medications that can help individuals lose weight by decreasing appetite, increasing feelings of fullness, or blocking the absorption of fat in the body. Some commonly prescribed weight loss drugs include:
- Orlistat (Xenical) – blocks the absorption of fat in the gut
- Phentermine (Adipex-P, Lomaira) – decreases appetite
- Liraglutide (Saxenda) – mimics a hormone that regulates appetite
- Naltrexone/bupropion (Contrave) – works on the brain to decrease appetite and increase feelings of fullness
- Phentermine/topiramate (Qsymia) – combines an appetite suppressant with a medication that affects the way the brain responds to food
- Lorcaserin (Belviq) – works on the brain to decrease appetite
It’s important to note that these medications should be used in conjunction with a healthy diet and exercise program, and should only be taken under the supervision of a healthcare provider. They also have side effects, and some have FDA warning on their label.
Mounjaro (Tirzepatide) is a medication that is currently being developed as a potential treatment for obesity and type 2 diabetes. It is a subcutaneous (injected under the skin) GLP-1 receptor agonist and ghrelin receptor antagonist. It is a combination of two medications that work on different hormones to regulate appetite and glucose metabolism.
GLP-1 receptor agonists mimic a hormone called GLP-1, which regulates appetite and insulin secretion, while ghrelin receptor antagonists block the activity of a hormone called ghrelin, which stimulates hunger. By targeting these hormones, Tirzepatide aims to decrease appetite and promote weight loss.
It is currently in phase 2b of clinical trials, and its safety and effectiveness have not yet been established. The FDA has not yet approved Tirzepatide for any use, and it is not yet available on the market. If it gets approval it would be prescribed by a healthcare provider and used in conjunction with a healthy diet and exercise program.
As Mounjaro (Tirzepatide) is currently in the clinical trial phase, the full range of potential side effects is not yet known. However, based on the mechanism of action of the medication, some common side effects that have been observed in trials include:
- Injection site reactions
It’s also important to note that as Tirzepatide is a medication that is being studied for the treatment of obesity, it could also cause weight loss. However, as the drug is still in the clinical trial phase, it is not yet available for general use and the side effects mentioned here are based on the limited data that is available so far. Also, it’s important to talk with your healthcare provider before starting any treatment, they will have the most current information on the medication and its potential side effects.